211 related articles for article (PubMed ID: 22586580)
1. ZnT8 is a major CD8+ T cell-recognized autoantigen in pediatric type 1 diabetes.
Énée É; Kratzer R; Arnoux JB; Barilleau E; Hamel Y; Marchi C; Beltrand J; Michaud B; Chatenoud L; Robert JJ; van Endert P
Diabetes; 2012 Jul; 61(7):1779-84. PubMed ID: 22586580
[TBL] [Abstract][Full Text] [Related]
2. Characterization of immune response to novel HLA-A2-restricted epitopes from zinc transporter 8 in type 1 diabetes.
Xu X; Gu Y; Bian L; Shi Y; Cai Y; Chen Y; Chen H; Qian L; Wu X; Xu K; Mallone R; Davidson HW; Yu L; She J; Zhang M; Yang T
Vaccine; 2016 Feb; 34(6):854-62. PubMed ID: 26541133
[TBL] [Abstract][Full Text] [Related]
3. Zinc transporter (ZnT)8(186-194) is an immunodominant CD8+ T cell epitope in HLA-A2+ type 1 diabetic patients.
Scotto M; Afonso G; Larger E; Raverdy C; Lemonnier FA; Carel JC; Dubois-Laforgue D; Baz B; Levy D; Gautier JF; Launay O; Bruno G; Boitard C; Sechi LA; Hutton JC; Davidson HW; Mallone R
Diabetologia; 2012 Jul; 55(7):2026-31. PubMed ID: 22526607
[TBL] [Abstract][Full Text] [Related]
4. Prediction of HLA class I-restricted T-cell epitopes of islet autoantigen combined with binding and dissociation assays.
Wu X; Xu X; Gu R; Wang Z; Chen H; Xu K; Zhang M; Hutton J; Yang T
Autoimmunity; 2012 Mar; 45(2):176-85. PubMed ID: 22260783
[TBL] [Abstract][Full Text] [Related]
5. Identification of novel HLA-A 0201-restricted cytotoxic T lymphocyte epitopes from Zinc Transporter 8.
Li S; Li H; Chen B; Lu D; Deng W; Jiang Y; Zhou Z; Yang Z
Vaccine; 2013 Mar; 31(12):1610-5. PubMed ID: 23246542
[TBL] [Abstract][Full Text] [Related]
6. Vagaries of the ELISpot assay: specific detection of antigen responsive cells requires purified CD8(+) T cells and MHC class I expressing antigen presenting cell lines.
Fuchs YF; Jainta GW; Kühn D; Wilhelm C; Weigelt M; Karasinsky A; Upadhyaya B; Ziegler AG; Bonifacio E
Clin Immunol; 2015 Apr; 157(2):216-25. PubMed ID: 25728493
[TBL] [Abstract][Full Text] [Related]
7. Human type 1 diabetes is associated with T cell autoimmunity to zinc transporter 8.
Dang M; Rockell J; Wagner R; Wenzlau JM; Yu L; Hutton JC; Gottlieb PA; Davidson HW
J Immunol; 2011 May; 186(10):6056-63. PubMed ID: 21471440
[TBL] [Abstract][Full Text] [Related]
8. Equivalent specificity of peripheral blood and islet-infiltrating CD8+ T lymphocytes in spontaneously diabetic HLA-A2 transgenic NOD mice.
Enée E; Martinuzzi E; Blancou P; Bach JM; Mallone R; van Endert P
J Immunol; 2008 Apr; 180(8):5430-8. PubMed ID: 18390725
[TBL] [Abstract][Full Text] [Related]
9. Identification of Candidate Tolerogenic CD8(+) T Cell Epitopes for Therapy of Type 1 Diabetes in the NOD Mouse Model.
Yu C; Burns JC; Robinson WH; Utz PJ; Ho PP; Steinman L; Frey AB
J Diabetes Res; 2016; 2016():9083103. PubMed ID: 27069933
[TBL] [Abstract][Full Text] [Related]
10. Prevention of "Humanized" diabetogenic CD8 T-cell responses in HLA-transgenic NOD mice by a multipeptide coupled-cell approach.
Niens M; Grier AE; Marron M; Kay TW; Greiner DL; Serreze DV
Diabetes; 2011 Apr; 60(4):1229-36. PubMed ID: 21346176
[TBL] [Abstract][Full Text] [Related]
11. Immunization of HLA class I transgenic mice identifies autoantigenic epitopes eliciting dominant responses in type 1 diabetes patients.
Blancou P; Mallone R; Martinuzzi E; Sévère S; Pogu S; Novelli G; Bruno G; Charbonnel B; Dolz M; Chaillous L; van Endert P; Bach JM
J Immunol; 2007 Jun; 178(11):7458-66. PubMed ID: 17513797
[TBL] [Abstract][Full Text] [Related]
12. Identification of autoreactive CD8+ T cell responses targeting chromogranin A in humanized NOD mice and type 1 diabetes patients.
Li Y; Zhou L; Li Y; Zhang J; Guo B; Meng G; Chen X; Zheng Q; Zhang L; Zhang M; Wang L
Clin Immunol; 2015 Jul; 159(1):63-71. PubMed ID: 25958206
[TBL] [Abstract][Full Text] [Related]
13. A novel triple mix radiobinding assay for the three ZnT8 (ZnT8-RWQ) autoantibody variants in children with newly diagnosed diabetes.
Vaziri-Sani F; Delli AJ; Elding-Larsson H; Lindblad B; Carlsson A; Forsander G; Ivarsson SA; Ludvigsson J; Marcus C; Lernmark Å
J Immunol Methods; 2011 Aug; 371(1-2):25-37. PubMed ID: 21708156
[TBL] [Abstract][Full Text] [Related]
14. Islet-specific CTL cloned from a type 1 diabetes patient cause beta-cell destruction after engraftment into HLA-A2 transgenic NOD/scid/IL2RG null mice.
Unger WW; Pearson T; Abreu JR; Laban S; van der Slik AR; der Kracht SM; Kester MG; Serreze DV; Shultz LD; Griffioen M; Drijfhout JW; Greiner DL; Roep BO
PLoS One; 2012; 7(11):e49213. PubMed ID: 23155466
[TBL] [Abstract][Full Text] [Related]
15. The cation efflux transporter ZnT8 (Slc30A8) is a major autoantigen in human type 1 diabetes.
Wenzlau JM; Juhl K; Yu L; Moua O; Sarkar SA; Gottlieb P; Rewers M; Eisenbarth GS; Jensen J; Davidson HW; Hutton JC
Proc Natl Acad Sci U S A; 2007 Oct; 104(43):17040-5. PubMed ID: 17942684
[TBL] [Abstract][Full Text] [Related]
16. Zinc transporter 8 autoantibodies and their association with SLC30A8 and HLA-DQ genes differ between immigrant and Swedish patients with newly diagnosed type 1 diabetes in the Better Diabetes Diagnosis study.
Delli AJ; Vaziri-Sani F; Lindblad B; Elding-Larsson H; Carlsson A; Forsander G; Ivarsson SA; Ludvigsson J; Kockum I; Marcus C; Samuelsson U; Örtqvist E; Groop L; Bondinas GP; Papadopoulos GK; Lernmark Å;
Diabetes; 2012 Oct; 61(10):2556-64. PubMed ID: 22787139
[TBL] [Abstract][Full Text] [Related]
17. Triple chimeric islet autoantigen IA2-ZnT8WR to facilitate islet autoantibody determination.
Yu L; Liu Y; Miao D; Wenzlau J; Davidson H; Hutton J; Eisenbarth GS
J Immunol Methods; 2010 Feb; 353(1-2):20-3. PubMed ID: 20035758
[TBL] [Abstract][Full Text] [Related]
18. Incidental CD8 T cell reactivity against caspase-cleaved apoptotic self-antigens from ubiquitously expressed proteins in islets from prediabetic human leucocyte antigen-A2 transgenic non-obese diabetic mice.
Coppieters KT; Amirian N; von Herrath MG
Clin Exp Immunol; 2011 Aug; 165(2):155-62. PubMed ID: 21605113
[TBL] [Abstract][Full Text] [Related]
19. Characterization of zinc transporter 8 (ZnT8) antibodies in autoimmune diabetic patients from Argentinian population using monomeric, homodimeric, and heterodimeric ZnT8 antigen variants.
Faccinetti NI; Guerra LL; Penas Steinhardt A; Iacono RF; Frechtel GD; Trifone L; Poskus E; Trabucchi A; Valdez SN
Eur J Endocrinol; 2016 Feb; 174(2):157-65. PubMed ID: 26567119
[TBL] [Abstract][Full Text] [Related]
20. The three ZNT8 autoantibody variants together improve the diagnostic sensitivity of childhood and adolescent type 1 diabetes.
Andersson C; Larsson K; Vaziri-Sani F; Lynch K; Carlsson A; Cedervall E; Jönsson B; Neiderud J; Månsson M; Nilsson A; Lernmark A; Elding Larsson H; Ivarsson SA
Autoimmunity; 2011 Aug; 44(5):394-405. PubMed ID: 21244337
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
